HCAT

HEALTH CATALYST, INC.

HCAT · CIK 1636422 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$307M
20192024
Net Income−$70M
20192024
Operating CF$15M
20192024
Free Cash Flow$13M
20192024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue$0.3B$0.3B$0.3B$0.2B$0.2B$0.2B
Cost of Revenue——————
Gross Profit——————
R&D Expense$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B
SG&A Expense——————
Operating Income$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B
Net Income$-0.1B$-0.1B$-0.1B$-0.2B$-0.1B$-0.1B
EPS (Basic)$-1.15$-2.09$-2.56$-3.23——
EPS (Diluted)$-1.15$-2.09$-2.63$-3.23——

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.9B$0.7B$0.8B$0.8B$0.6B$0.3B
Current Assets$0.5B$0.4B$0.4B$0.5B$0.3B$0.3B
Cash & Equivalents$0.2B$0.1B$0.1B$0.2B$0.1B$0.0B
Total Liabilities$0.5B$0.3B$0.3B$0.3B$0.3B$0.1B
Current Liabilities$0.3B$0.1B$0.1B$0.1B$0.1B$0.0B
Stockholders' Equity$0.4B$0.4B$0.4B$0.5B$0.3B$0.2B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$0.0B$-0.0B$-0.1B$-0.1B$-0.2B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.2B$0.0B$-0.0B$0.3B$0.2B$0.2B
← Companies